Retatrutide is a new pharmaceutical in the fight against obesity. This novel drug, belonging to a dual GLP-1 and GIP receptor agonist, shows promising results in research studies. By activating these receptors, https://idaytvv634573.blog5.net/81875802/tirzepatide-a-promising-new-treatment-for-obesity